Johnson & Johnson (JNJ)

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Ask a question about Johnson & Johnson (JNJ)
Company Performance

Current Price

as of Nov 13, 2024

$153.24

P/E Ratio

25.33

Market Cap

$368.94B

Description

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in the interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.

Metrics

Overview

  • HQNew Brunswick, NJ
  • SectorHealth Technology
  • IndustryPharmaceuticals: Major
  • TickerJNJ
  • Price$153.24+0.39%

Trading Information

  • Market cap$368.94B
  • Float99.88%
  • Average Daily Volume (1m)6,681,114
  • Average Daily Volume (3m)6,134,405
  • EPS$6.10

Company

  • Revenue$87.69B
  • Rev growth (1yr)5.27%
  • Net income$2.69B
  • Gross margin69.19%
  • EBITDA margin30.98%
  • EBITDA$6.96B
  • EV$407.32B
  • EV/Revenue4.64
  • P/E25.33
  • P/S4.24
  • P/B5.26
Documents
Factset Street Account